Смотреть видео онлайн

Dr. Brose on Vandetanib for Differentiated Thyroid Cancer

   
- HD качество

В базе 44 видео
Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance
Загружен 24 мая 2011
In April, the U.S. Food and Drug Administration approved the use of vandetanib for the treatment of medullary thyroid carcinoma. MD Anderson's Dr. Robert ...

Dr. Brose on Vandetanib for Differentiated Thyroid Cancer
Загружен 5 февраля 2014
Marcia S. Brose, MD, PhD, assistant professor, Abramson Cancer Center, Department of Otolaryngology, Head & Neck Surgery, Department of Medicine, ...

Dr. Marcia Brose Describes Sorafenib in RAI-Resistant Differentiated Thyroid Cancer
Загружен 14 июня 2013
Marcia Brose, MD, PhD, an assistant professor of otolaryngology and head and neck surgery in the Abramson Cancer Center and the Perelman School of ...

Prof. L. Wirth - Advanced differentiated thyroid cancer
Загружен 26 ноября 2015
Listen to the Italian translation here: https://youtu.be/EqxxhfnzwK8 Find out more about ITCO Foundation here:

Thyroid Cancer Treatment | Thyroid Surgery in Los Angeles by Dr. Babak Larian
Загружен 2 июня 2010
Thyroid surgery (thyroidectomy) can be very effective as a thyroid cancer treatment option. It's a minimally invasive procedure that is performed on an outpatient ...

Dr. Marcia Brose on Sorafenib in Radioactive Iodine-Resistant Thyroid Cancer
Загружен 3 июня 2013
Marcia Brose, MD, PhD, and an assistant professor of otolaryngology and head and neck surgery in the Abramson Cancer Center and the Perelman School of ...

Sorafenib Extends Survival in Differentiated Thyroid Cancer
Загружен 3 июня 2013
A new trial has found that sorafenib may help extend the survival of patients with differentiated thyroid cancer. In the phase-III DECISION trial, progression-free ...

Dr. Langmuir on the Advantages of Vandetanib in Medullary Thyroid Cancer
Загружен 15 марта 2011
Peter Langmuir, M.D. Executive Director, Medical Science AstraZeneca on the Advantages of Vandetanib in Medullary Thyroid Cancer.

Dr. Langmuir on Vandetanib in Medullary Thyroid Cancer
Загружен 15 марта 2011
Peter Langmuir, M.D. Executive Director, Medical Science AstraZeneca on Vandetanib in Medullary Thyroid Cancer.

Dr. Brose Discusses Lenvatinib for the Treatment of Patients With Thyroid Cancer
Загружен 2 сентября 2015
Marcia S. Brose, MD, PhD, associate professor of Otorhinolaryngology, Head and Neck Surgery at the Hospital of the University of Pennsylvania, discusses the ...

Dr. Wirth on the Use of Lenvatinib in Hypertensive Patients With Thyroid Cancer
Загружен 18 июня 2018
Lori J. Wirth, MD, associate professor, Medicine, Harvard Medical School, medical director, Center for Head and Neck Cancers, Massachusetts General Hospital ...

Vandetanib improves PFS in thyroid cancer
Загружен 6 ноября 2014
Visit (Hospital Universitario Ramón y Cajal, Madrid, Spain) talks to ecancertv at ESMO 2014 about his work looking ...

TKIs for treating medullary thyroid cancer
Загружен 29 ноября 2018
Until recently, there was no effective treatment option for disseminative or non-operative medullary thyroid cancer (MTC). However, tyrosine kinase inhibitors ...

Prof. M. Schlumberger - Vandetanib in patients with medullary thyroid cancer
Загружен 18 октября 2016
Listen to the Italian translation here: https://youtu.be/G2BRoVPdMlc Find out more on ITCO Foundation:

Reversal of Cushing's Syndrome by Vandetanib in Medullary Thyroid Carcinoma
Загружен 8 декабря 2014
prezi link: https:///iohpyahnwsng/reversal-of-cushings-syndrome-by-vandetanib-in-medullary-th/

 1 2 3 » 

Мир в онлайне